(11aS)-Dibenzo[d,f][1,3]dioxepin-1,11-diylbis[diphenylphosphine], 97%, 1g

4-(methylthio)-2-piperazin-1-yl-1,3-benzothiazole, 95.0%, 250mg

1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidine-3-carboxylic acid, 95.0%, 10g

3-Amino-2-cyano-5-(4-fluorophenyl)thiophene, 250mg

1,3,2-Dioxaborolane, 2-[4-chloro-3-(difluoromethyl)phenyl]-4,4,5,5-tetramethyl-, 95%, 250mg

Cetilistat>98.0%(HPLC)5g

(1s,3s)-1-(4-Chlorophenyl)-3-hydroxycyclobutanecarboxylic acid, 97%, 250mg

Acridine orange hydrochloride hydrate, (CI 46005) for microscopy, 1 g, glass packaging

2-[(6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl)oxy]propanoic acid, 95.0%, 1g

3,3,5,5-Tetramethylbenzidine dihydrochloride, 1 g

4-Nitrophenyl 4-(pyridin-2-yldisulfanyl)benzyl carbonate, 97.0%, 1g

Analytical balance ADJ series with internal automatic calibration for temperature changes >=2°C or time-controlled, 120 g, ADJ 100-4 (W)

1-Pyrrolidinecarboxylic acid, 2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-, 1,1-dimethylethyl ester, (2S)-, 98%, 10g